홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
KYMR
#901
Kymera Therapeutics, Inc. Common Stock
91.350
0
+1.44%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+1.44%
월간 변동
+25.93%
6달 변화
+54.57%
년간 변동율
+54.57%
이전 종가
90.050
0
Open
91.380
0
Bid
Ask
Low
91.350
0
High
91.380
0
양
150
마켓
주식
헬스케어
KYMR
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
44.81 M
51.7 M
55.18 M
61.11 M
64.94 M
81.64 M
—
Valuation ratios
Enterprise value
2.75 B
3.23 B
1.3 B
1.44 B
2.49 B
6 B
14.43 B
Price to earnings ratio
—
—
-8.66
-10.06
-13.5
-21.09
-58.15
Price to sales ratio
—
—
28.61
18.83
64.14
—
—
Price to cash flow ratio
—
—
-8.75
-14.39
-15.52
28.23
-13.71
Price to book ratio
—
—
2.73
3.75
3.61
4.16
7.04
Enterprise value to EBITDA ratio
—
—
—
—
-8.27
—
—
Profitability ratios
Return on assets %
0.09
0.17
0.26
0.26
0.23
0.18
0.26
Return on equity %
0.16
0.22
0.32
0.37
0.27
0.2
0.3
Return on invested capital %
65.97
160.54
290.93
—
—
199.2
—
Gross margin %
100
100
100
100
0
0
0
Operating margin %
136.05
138.03
344.37
210.62
555.82
891.07
7 830.73
EBITDA margin %
—
—
—
—
-640.16
-969.87
-8 054.78
Net margin %
133.96
137.6
330.6
186.99
475.57
794.04
6 967.04
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
2.73
4.88
5.88
4.73
7.53
10.47
34.66
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.13
0.08
0.13
0.06
0.03
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2.84
1.76
2.59
2.76
2.83
EBIT per share
—
—
—
—
-4.11
-4.6
-4.68
EBITDA per share
—
—
—
—
-4.02
-4.5
-4.58
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
7.55
6.42
6.51
10.04
29.88
Net current asset value per share
—
—
7.78
6.94
6.8
10.31
31.67
Tangible book value per share
—
—
9.09
6.77
11.14
18.7
51.42
Working capital per share
—
—
6.45
5.48
5.9
9.33
28.04
Book value per share
—
—
9.09
6.77
11.14
18.7
51.42
뉴스
Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway
모건 스탠리, 카이메라 테라퓨틱스 목표 주가 하향 조정
Morgan Stanley cuts Kymera Therapeutics stock price target on pipeline progress
RBC 캐피털, 키메라 테라퓨틱스 목표가 상향
카이메라 테라퓨틱스, RBC 캐피탈, 목표 주가 상향
RBC Capital raises Kymera Therapeutics price target on pipeline progress
RBC Capital raises Kymera Therapeutics price target on pipeline
Stifel, Kymera Therapeutics에 ’매수’ 등급 재확인, 목표가 $114
Stifel reiterates Buy rating on Kymera Therapeutics stock at $114
Kymera Q4 2025 slides: pipeline advances despite revenue miss
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates
카이메라 테라퓨틱스, 5억 달러 규모의 시장 조성 주식 공모 개시